Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Proc Natl Acad Sci U S A ; 109(42): E2875-84, 2012 Oct 16.
Artículo en Inglés | MEDLINE | ID: mdl-23027969

RESUMEN

Although the protooncogene c-Jun plays a critical role in cell proliferation, cell death, and malignant transformation, DNA microarray screens have identified only a few human cancer types with aberrant expression of c-Jun. Here, we show that c-Jun accumulation is robustly elevated in human glioblastoma and that this increase contributes to the malignant properties of the cells. Most importantly, the increase in c-Jun protein accumulation occurs with no corresponding increase in c-Jun mRNA or the half-life of the c-Jun protein but, rather, in the translatability of the transcript. The c-Jun 5'UTR harbors a potent internal ribosomal entry site (IRES) with a virus-like IRES domain that directs cap-independent translation in glioblastoma cells. Accumulation of c-Jun is not dependent on MAPK activity but can be stimulated by a cytoskeleton-dependent pathway. Our findings provide evidence that human c-Jun is an IRES-containing cellular transcript that contributes to cancer development through translational activation. This previously undescribed mechanism of c-Jun regulation might also be relevant to other types of human cancer and offers unique potential targets for therapy.


Asunto(s)
Regulación Neoplásica de la Expresión Génica/fisiología , Glioblastoma/metabolismo , Biosíntesis de Proteínas/fisiología , Proteínas Proto-Oncogénicas c-jun/metabolismo , Ribosomas/metabolismo , Animales , Western Blotting , Células Cultivadas , Regulación Neoplásica de la Expresión Génica/genética , Humanos , Inmunohistoquímica , Luciferasas , Biosíntesis de Proteínas/genética , Ratas , Ratas Sprague-Dawley
2.
J Biol Chem ; 283(1): 110-119, 2008 Jan 04.
Artículo en Inglés | MEDLINE | ID: mdl-17984088

RESUMEN

Restriction of glutamine synthetase to the nervous system is mainly achieved through the mutual function of the glucocorticoid receptor and the neural restrictive silencing factor, NRSF/REST. Glucocorticoids induce glutamine synthetase expression in neural tissues while NRSF/REST represses the hormonal response in non-neural cells. NRSF/REST is a modular protein that contains two independent repression domains, at the N and C termini of the molecule, and is dominantly expressed in nonneural cells. Neural tissues express however splice variants, REST4/5, which contain the repression domain at the N, but not at the C terminus of the molecule. Here we show that full-length NRSF/REST or its C-terminal domain can inhibit almost completely the induction of gene transcription by glucocorticoids. By contrast, the N-terminal domain not only fails to repress the hormonal response but rather stimulates it markedly. The inductive activity of the N-terminal domain is mediated by hBrm, which is recruited to the promoter only in the concomitant presence of GR. Importantly, a similar inductive activity is also exerted by the splice variant REST4. These findings raise the possibility that NRSF/REST exhibits a dual role in regulation of glutamine synthetase. It represses gene induction in nonneural cells and enhances the hormonal response, via its splice variant, in the nervous system.


Asunto(s)
Regulación de la Expresión Génica/efectos de los fármacos , Glucocorticoides/farmacología , Proteínas Represoras/fisiología , Factores de Transcripción/fisiología , Animales , Sitios de Unión/genética , Western Blotting , Células COS , Línea Celular Tumoral , Células Cultivadas , Pollos , Chlorocebus aethiops , Vectores Genéticos/genética , Células HeLa , Humanos , Inmunoprecipitación , Regiones Promotoras Genéticas/genética , Receptores de Glucocorticoides/metabolismo , Proteínas Represoras/genética , Proteínas Represoras/metabolismo , Retina/citología , Retina/efectos de los fármacos , Retina/metabolismo , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Transcripción Genética/efectos de los fármacos , Activación Transcripcional , Levaduras/genética , Levaduras/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA